RaySearch Laboratories AB has received regulatory market approval by the Chinese regulatory agency CFDA for RaySearch’s treatment planning system RayStation. The approval means that RayStation can now be sold on the Chinese market.

Despite evidence that contralateral prophylactic mastectomy (CPM) does not improve survival rates, an increasing number of young women with breast cancer elect to remove their healthy breast to avoid recurrence and improve survival.

Zotec Partners LLC announced that it has signed a definitive agreement to acquire 100% of the stock of Medical Management Professionals Inc. (MMP).

According to the KLAS report Clinical Market Share 2013: More than Meaningful Use, Cerner Corporation and Epic Systems combined captured more than three-fourths of new large-hospital electronic medical records (EMR) contracts, while the other vendors struggled to keep pace.

radiation therapy radiontherapy cyberknife tomotherapy systems

Accuray Incorporated announced that studies presented at the American Society for Radiation Oncology (ASTRO) 55th Annual Meeting continue to reinforce evidence of clinical and quality of life benefits for the CyberKnife and TomoTherapy Systems.

The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services (CMS) decision to allow only Coverage with Evidence Development (CED) for an Alzheimer's imaging test that would improve diagnostic accuracy and certainty in challenging cases. When used in specific populations, as outlined in criteria developed by the Alzheimer's Association and the Society for Nuclear Medicine and Molecular Imaging (SNMMI), this tool has the potential to help identify amyloid in the brain, a hallmark of Alzheimer's disease, and resolve distressing medical uncertainty.

Immediate U.S. government furloughs affecting virtually all National Science Foundation (NSF) employees and three-fourths of those at the National Institutes of Health (NIH) could impact U.S. competitiveness, American Association for the Advancement of Science (AAAS) warned.

The Arthritis Foundation awarded $1 million to the Hospital for Special Surgery in New York City, University of California-San Francisco (UCSF) and Mayo Clinic in Rochester, Minn. to validate the use of new magnetic resonance imaging (MRI) techniques and newly identified biomarkers.

Esteya, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), enabling medical centers in the United States to offer their patients with skin cancer a new treatment option.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now